Continue to content
BHS Webinar supported by GSK

BHS Webinar supported by GSK

Navigating Innovations in Multiple Myeloma Treatment at First Relapse

17 March 2026 - 17 March 2026
Organised by
BHS
In collaboration with
GSK

Program:

20:00 – 20:15: Setting the scene: Reconciling the EHA-EMN guidelines with the Belgian landscape at first relapse – Dr. Rutger Callens, AZ Delta

20:15 – 20:30: Making it practical: efficacy, safety, and eligibility considerations for BCMA options versus standard of care at first relapse – Dr. Ornella Rizzo, Institut Jules Bordet

20:30 – 20:45: Planning ahead: potential strategies for further treatment in case of relapse on a BCMA option - Michel Delforge, UZ Leuven

20:45 – 21:00: Q&A/discussion – moderated by Dr. Marie Vercruyssen, Institut Jules Bordet

  • International Symposium on Hodgkin Lymphoma (ISHL14)

    3/10/2026 - 5/10/2026
    Discover the latest advancements and global perspectives in Hodgkin Lymphoma at 14th International Symposium 
  • 41st General Annual Meeting of the Belgian Hematology Society 2026

    6/02/2026 - 7/02/2026
    Dolce La Hulpe Brussels